This stems from their direct involvement in tau-related pathology and the extensive therapeutic avenues opened through modulating these chaperones' interactions, such as the observed neuroprotection against β-amyloid toxicity linked to elevated HSP70 levels in AD research (Magrané et al., 2004). Here, MAPT is linked to Alzheimer disease.